Executives

Group management

Anders Lönner, Chief Executive Officer Born 1945. Fil. Pol. Mag. Group president and CEO of Meda since 1999. Board member of Meda and Valeant Pharmaceuticals International. Shares in Meda: 4,677,654. Call options in Meda: 250,000*

Dr. Jörg-Thomas Dierks, Chief Operating Officer Year of birth: 1960. Physician. Previously senior vice president for commercial operations and Chief Operating Officer of Viatris and before that, of ASTA-Medica. Employed since 2005. Shares in Meda: 151,798. Call options in Meda: 250,000*

Henrik Stenqvist, Chief Financial Officer Born 1967. BSc in economics. Previously CFO of subsidiaries within AstraZeneca. Employed since 2003. Shares in Meda: 190,605. Call options in Meda: 50,000*

Others

Sharon Clarke, General Manager Meda USA Born 1963. BA in microbiology. Employed since 2007. Previously Vice President of Sales, MedPointe Pharmaceuticals. Shares in Meda: 33,671.

Erik Haeffler, Vice President Supply Chain & Manufacturing Born 1967. BSc. Previous experience from manufacturing and supply chain at AstraZeneca. Employed since 2009. Shares in Meda: 1,000.

Hans-Jürgen Kromp, Vice President Group Services Born 1953. Lawyer. Previously general counsel of ASTA Medica and Viatris and before that, head of legal affairs at Sandoz and Novartis, Germany. Employed since 2005. Shares in Meda: 52,045.

Anders Larnholt, Vice President Corporate Development & Investor Relations Born 1972. BSc in economics and MSc. Previously with Credit Suisse First Boston. Employed since 2000. Shares in Meda: 69,300. Call options in Meda: 50,000*

Mårten Österlund, Vice President Business Development Born 1957. PhD in molecular biology from Uppsala University. Has researched at the Pasteur Institute in Paris. Experience from development companies, including an executive position at Karo Bio. Employed since 2005. Shares in Meda: 105,644.

* Issued by Stena Sessan Rederi AB.